Eli Lilly Net Income 2010-2024 | LLY

Eli Lilly net income for the twelve months ending September 30, 2024 was $8.370B, a 67.79% increase year-over-year.

  • Eli Lilly annual net income for 2023 was $5.24B, a 16.08% decline from 2022.
  • Eli Lilly annual net income for 2022 was $6.245B, a 11.88% increase from 2021.
  • Eli Lilly annual net income for 2021 was $5.582B, a 9.88% decline from 2020.

Eli Lilly Net Income 2010-2024 | LLY

  • Eli Lilly annual net income for 2023 was $5.24B, a 16.08% decline from 2022.
  • Eli Lilly annual net income for 2022 was $6.245B, a 11.88% increase from 2021.
  • Eli Lilly annual net income for 2021 was $5.582B, a 9.88% decline from 2020.
Related Stocks
Company NameMarket
Cap
Novo Nordisk (NVO)$460.6B
Johnson & Johnson (JNJ)$368.4B
AbbVie (ABBV)$294.4B
Merck (MRK)$244.2B
Novartis AG (NVS)$211.1B
AstraZeneca (AZN)$197.8B
Pfizer (PFE)$142.2B
Sanofi (SNY)$121.8B
Innoviva (INVA)$1.2B